Cleared Traditional

K022178 - CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM
(FDA 510(k) Clearance)

Nov 2002
Decision
132d
Days
Class 2
Risk

K022178 is an FDA 510(k) clearance for the CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM. This device is classified as a System, Test, Immunological, Antigen, Tumor (Class II - Special Controls, product code MOI).

Submitted by Bayer Diagnostics Corp. (Tarrytown, US). The FDA issued a Cleared decision on November 12, 2002, 132 days after receiving the submission on July 3, 2002.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K022178 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2002
Decision Date November 12, 2002
Days to Decision 132 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MOI — System, Test, Immunological, Antigen, Tumor
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — MOI System, Test, Immunological, Antigen, Tumor

All 27
Access BR Monitor
K240403 · Beckman Coulter, Inc. · May 2024
IMMULITE? 2000 BR-MA
K233946 · Siemens Healthcare Diagnostics Products, Ltd. · Mar 2024
Lumipulse G CA15-3
K192524 · Fujirebio Diagnostics,Inc. · Sep 2020
ADVIA Centaur BR
K193489 · Siemens Healthcare Diagnostics, Inc. · Feb 2020
ADVIA Centaur CA 15-3 assay
K192777 · Siemens Healthcare Diagnostics, Inc. · Nov 2019
Elecsys CA 15-3 II
K181492 · Roche Diagnostics · Jun 2018